BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6778498)

  • 1. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular origin and ultrastructure of platelet-derived microparticles.
    Ponomareva AA; Nevzorova TA; Mordakhanova ER; Andrianova IA; Rauova L; Litvinov RI; Weisel JW
    J Thromb Haemost; 2017 Aug; 15(8):1655-1667. PubMed ID: 28561434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Growth Inhibitory Effect of Platelet Activating Factor C-16 and Its Structural Analogs on Mycobacteria.
    Riaz MS; Kaur A; Shwayat SN; Behboudi S; Kishore U; Pathan AA
    Front Microbiol; 2018; 9():1903. PubMed ID: 30258409
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of rebamipide, a novel anti-ulcer agent, on gastric mucosal injury induced by platelet-activating factor in rats.
    Kokura S; Yoshikawa T; Naito Y; Ichikawa H; Takano H; Takahashi S; Tomii T; Yoshida N; Kondo M
    Dig Dis Sci; 1997 Dec; 42(12):2566-71. PubMed ID: 9440637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
    Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
    Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac release of chemoattractants after ischaemia induced by coronary balloon angioplasty.
    Neumann FJ; Richardt G; Schneider M; Ott I; Haupt HM; Tillmanns H; Schömig A; Rauch B
    Br Heart J; 1993 Jul; 70(1):27-34. PubMed ID: 8037995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action.
    Fouque F; Joseph D; Vargaftig BB
    Agents Actions; 1982 Dec; 12(5-6):720-2. PubMed ID: 7164947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.
    Benveniste J; Roubin R; Chignard M; Jouvin-Marche E; Le Couedic JP
    Agents Actions; 1982 Dec; 12(5-6):711-3. PubMed ID: 7164945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aspirin on platelet aggregation in diabetes mellitus.
    Khosla PK; Seth V; Tiwari HK; Saraya AK
    Diabetologia; 1982 Aug; 23(2):104-7. PubMed ID: 7128964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor.
    Camussi G; Pawlowski I; Tetta C; Roffinello C; Alberton M; Brentjens J; Andres G
    Am J Pathol; 1983 Jul; 112(1):78-88. PubMed ID: 6859232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets.
    Touqui L; Chignard M; Jacquemin C; Wal F; Vargaftig BB
    Experientia; 1984 Apr; 40(4):374-7. PubMed ID: 6714369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-O-alkyl-linked phosphoglycerides of human platelets: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species.
    Mueller HW; Purdon AD; Smith JB; Wykle RL
    Lipids; 1983 Nov; 18(11):814-9. PubMed ID: 6419001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of platelet-activating factor by blood platelets and plasma.
    Alam I; Smith JB; Silver MJ
    Lipids; 1983 Aug; 18(8):534-8. PubMed ID: 6413803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective platelet aggregation to the calcium ionophore A23187 in a patient with a lifelong bleeding disorder.
    Machin SJ; Keenan JP; McVerry BA
    J Clin Pathol; 1983 Oct; 36(10):1140-4. PubMed ID: 6413552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology and biochemistry of platelet-activating factor.
    O'Flaherty JT; Wykle RL
    Clin Rev Allergy; 1983 Sep; 1(3):353-67. PubMed ID: 6370406
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine.
    O'Flaherty JT; Swendsen CL; Lees CJ; McCall CE
    Am J Pathol; 1981 Nov; 105(2):107-13. PubMed ID: 6271016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation.
    Lewis AJ; Dervinis A; Chang J
    Agents Actions; 1984 Dec; 15(5-6):636-42. PubMed ID: 6152379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of platelet activating factor on guinea-pig papillary muscle.
    Camussi G; Alloatti G; Montrucchio G; Meda M; Emanuelli G
    Experientia; 1984 Jul; 40(7):697-9. PubMed ID: 6086382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked.
    Touqui L; Hatmi M; Vargaftig BB
    Biochem J; 1985 Aug; 229(3):811-6. PubMed ID: 4052028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral mediators of pulmonary edema.
    Malik AB; Selig WM; Burhop KE
    Lung; 1985; 163(4):193-219. PubMed ID: 3930896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.